Login to Your Account



Asymchem inks deal aiming to bring foreign drugs into China

By Elise Mak
Staff Writer

Wednesday, May 16, 2018

HONG KONG – China's Asymchem Laboratories (Tianjin) Co. Ltd. joined hands with a top private equity firm and two government-backed parties to spearhead drug innovation in the northeastern city of Tianjin to bring novel drugs from overseas into the Chinese market.

To continue reading subscribe now to BioWorld Asia (formerly International)

Learn More about BioWorld Asia (formerly International)

Already a subscriber? Sign In or Buy now to activate your subscription